Patents by Inventor Werner Lubitz

Werner Lubitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Rapid bacteria test
    Patent number: 11906497
    Abstract: The invention relates to methods and devices for quantitative determination of bacteria.
    Type: Grant
    Filed: September 28, 2020
    Date of Patent: February 20, 2024
    Assignee: Swiss Analyze Bacteria AG
    Inventors: Dieter Ebert, Mathias Reichl, Werner Lubitz
  • BACTERIAL PREPARATIONS FOR ICE NUCLEATION
    Publication number: 20220348614
    Abstract: The present invention relates to bacterial preparations comprising ice nucleation proteins. Such bacterial preparations can in particular be used for the production of snow or rain, for hail suppression or for fog dispersal.
    Type: Application
    Filed: September 29, 2020
    Publication date: November 3, 2022
    Applicant: Logon Patentverwertungs-Verwaltungs GmbH
    Inventors: Werner LUBITZ, Mascha RESCH, Johannes KASSMANNHUBER
  • RAPID BACTERIA TEST
    Publication number: 20210018483
    Abstract: The invention relates to methods and devices for quantitative determination of bacteria.
    Type: Application
    Filed: September 28, 2020
    Publication date: January 21, 2021
    Applicant: Swiss Analyze Bacteria AG
    Inventors: Dieter EBERT, Mathias REICHL, Werner LUBITZ
  • Rapid test for bacteria
    Patent number: 10823719
    Abstract: The invention relates to methods and devices for quantitative determination of bacteria.
    Type: Grant
    Filed: August 17, 2016
    Date of Patent: November 3, 2020
    Assignee: Swiss Analyze Bacteria AG
    Inventors: Dieter Ebert, Mathias Reichl, Werner Lubitz
  • Bacterial ghosts for the treatment of cancer
    Patent number: 10772944
    Abstract: The present invention relates to a composition comprising Bacterial Ghosts, optionally an active agent, and a pharmaceutically acceptable carrier and/or excipient for use in the treatment of cancer.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: September 15, 2020
    Assignee: BIRD-C GMBH
    Inventors: Werner Lubitz, Pavol Kudela, Marek Sramko
  • Fed-batch process for the production of bacterial ghosts
    Patent number: 10526574
    Abstract: The invention relates to a fed-batch process for the production of bacterial ghosts based on the decoupling of the lytic gene expression and actual lysis of bacterial cells.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: January 7, 2020
    Assignee: Bird-C GmbH & Co. KG
    Inventors: Werner Lubitz, Christian Herwig, Timo Langemann, Patrick Sagmeister
  • BACTERIAL GHOSTS FOR THE TREATMENT OF CANCER
    Publication number: 20190030146
    Abstract: The present invention relates to a composition comprising Bacterial Ghosts, optionally an active agent, and a pharmaceutically acceptable carrier and/or excipient for use in the treatment of cancer.
    Type: Application
    Filed: January 20, 2017
    Publication date: January 31, 2019
    Applicant: BIRD-C GMBH
    Inventors: Werner Lubitz, Pavol Kudela, Marek Sranko
  • RAPID TEST FOR BACTERIA
    Publication number: 20180238849
    Abstract: The invention relates to methods and devices for quantitative determination of bacteria.
    Type: Application
    Filed: August 17, 2016
    Publication date: August 23, 2018
    Applicant: SWISS ANALYZE BACTERIA AG
    Inventors: Dieter EBERT, Mathias REICHL, Werner LUBITZ
  • FED-BATCH PROCESS FOR THE PRODUCTION OF BACTERIAL GHOSTS
    Publication number: 20180201895
    Abstract: The invention relates to a fed-batch process for the production of bacterial ghosts based on the decoupling of the lytic gene expression and actual lysis of bacterial cells.
    Type: Application
    Filed: February 20, 2015
    Publication date: July 19, 2018
    Applicant: BIRD-C GMBH & CO KG
    Inventors: Werner LUBITZ, Christian HERWIG, Timo LANGEMANN, Patrick SAGMEISTER
  • Vaccine for tumor immunotherapy
    Patent number: 9790260
    Abstract: The present invention relates to a vaccine comprising dendritic cells and bacterial ghosts for tumor immunotherapy.
    Type: Grant
    Filed: October 31, 2012
    Date of Patent: October 17, 2017
    Inventor: Werner Lubitz
  • Bacterial ghosts as carrier and targeting vehicles
    Patent number: 9763890
    Abstract: The invention concerns the use of bacterial ghosts as carrier and targeting vehicles for active substances.
    Type: Grant
    Filed: April 6, 2016
    Date of Patent: September 19, 2017
    Assignee: WERNER LUBITZ
    Inventor: Werner Lubitz
  • Bacterial ghosts for mediating innate immunity
    Patent number: 9415017
    Abstract: The invention relates to the use of bacterial ghosts (BG) to promote an innate immune response.
    Type: Grant
    Filed: August 4, 2011
    Date of Patent: August 16, 2016
    Inventor: Werner Lubitz
  • BACTERIAL GHOSTS AS CARRIER AND TARGETING VEHICLES
    Publication number: 20160220499
    Abstract: The invention concerns the use of bacterial ghosts as carrier and targeting vehicles for active substances.
    Type: Application
    Filed: April 6, 2016
    Publication date: August 4, 2016
    Inventor: Werner Lubitz
  • MINICIRCLE VECTOR PRODUCTION
    Publication number: 20140065705
    Abstract: A plasmid is provided comprising the following functional units: a prokaryotic origin of replication, a marker sequence, two specific recombinase recognition sequences and a multiple cloning site, whereby it comprises a gene coding for a sequence specific recombinase, whereby the units are arranged on the plasmid in such a way that the plasmid is divided into a miniplasmid and a minicircle upon expression of the sequence specific recombinase, said miniplasmid comprising the prokaryotic origin of replication, the marker sequence and the gene for the sequence specific recombinase and said minicircle comprising the multiple cloning site.
    Type: Application
    Filed: July 2, 2013
    Publication date: March 6, 2014
    Inventors: Peter MAYRHOFER, Wolfgang JECHLINGER, Werner LUBITZ
  • Minicircle vector production
    Patent number: 8647863
    Abstract: A plasmid is provided comprising the following functional units: a prokaryotic origin of replication, a marker sequence, two specific recombinase recognition sequences and a multiple cloning site, whereby it comprises a gene coding for a sequence specific recombinase, whereby the units are arranged on the plasmid in such a way that the plasmid is divided into a miniplasmid and a minicircle upon expression of the sequence specific recombinase, said miniplasmid comprising the prokaryotic origin of replication, the marker sequence and the gene for the sequence specific recombinase and said minicircle comprising the multiple cloning site.
    Type: Grant
    Filed: May 4, 2004
    Date of Patent: February 11, 2014
    Inventors: Peter Mayrhofer, Wolfgang Jechlinger, Werner Lubitz
  • Virus-modified bacteria ghosts
    Patent number: 8568738
    Abstract: The invention relates to virus-modified bacteria ghosts and the use thereof, for example, as carrier and targeting vehicles for active ingredients.
    Type: Grant
    Filed: July 28, 2008
    Date of Patent: October 29, 2013
    Inventor: Werner Lubitz
  • Vaccine for Tumor Immunotherapy
    Publication number: 20130115245
    Abstract: The present invention relates to a vaccine comprising dendritic cells and bacterial ghosts for tumor immunotherapy.
    Type: Application
    Filed: October 31, 2012
    Publication date: May 9, 2013
    Inventor: Werner Lubitz
  • BACTERIAL GHOSTS AS CARRIER AND TARGETING VEHICLES
    Publication number: 20120040829
    Abstract: The invention concerns the use of bacterial ghosts as carrier and targeting vehicles for active substances.
    Type: Application
    Filed: October 26, 2011
    Publication date: February 16, 2012
    Inventors: Werner Lubitz, Veronika Huter
  • BACTERIAL GHOSTS FOR MEDIATING INNATE IMMUNITY
    Publication number: 20120034268
    Abstract: The invention relates to the use of bacterial ghosts (BG) to promote an innate immune response.
    Type: Application
    Filed: August 4, 2011
    Publication date: February 9, 2012
    Inventor: Werner LUBITZ
  • Bacterial ghost (BG) production process using betapropiolactone (BPL) for final inactivation
    Patent number: 7968323
    Abstract: The invention relates to bacterial ghost preparation using betapropiolactone for final inactivation of bacteria.
    Type: Grant
    Filed: January 21, 2009
    Date of Patent: June 28, 2011
    Inventor: Werner Lubitz